Preliminary evaluation of extended-release naltrexone in Michigan and Missouri drug courts

Journal of Substance Abuse Treatment

Volumn 41, Issue 3, 2011, Pages 288-293

  Finigan, Michael W ^a   Perkins, Tamara ^a   Zold Kilbourn, Phyllis ^b   Parks, Joseph ^c   Stringer, Mark ^c  

^a Northwest Prof Consortium Inc   (United States)

^b Under contract to Northwest Professional Consortium Inc   (United States)

^c MISSOURI DEPARTMENT OF HEALTH AND SENIOR SERVICES   (United States)

Author keywords

Alcohol dependence; Criminal justice; Law enforcement; Naltrexone; Vivitrol

Indexed keywords

NALTREXONE;

ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COURT; DRUG EFFICACY; DRUG SCREENING; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; UNITED STATES;

ADULT; ALCOHOL DRINKING; ALCOHOLISM; AUTOMOBILE DRIVING; CRIMINAL LAW; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MICHIGAN; MISSOURI; NALTREXONE; NARCOTIC ANTAGONISTS; PILOT PROJECTS; RETROSPECTIVE STUDIES; SUBSTANCE ABUSE DETECTION; SUBSTANCE WITHDRAWAL SYNDROME; TEMPERANCE;

EID: 80052328435     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2011.04.003     Document Type: Article

References (24)

1. ADAW Missouri requires providers to offer medication-assisted treatment. Alcoholism and Drug Abuse Weekly 2009, 21:3.
2. Bhati Avi. Studying the effects of incarceration on offending trajectories. Urban Institute Policy Center Accessed online (2/10/2011) at:. http://www.urban.org/publications/411427.html.
3. Carey S.M., Finigan M.W., Crumpton D., Waller M.S. California drug courts: Outcomes, costs and promising practices: An overview of phase II in a statewide study. Journal of Psychoactive Drugs 2006, 38(4):345-356.
4. Carey S.M., Waller M.S., Marchand G. Kalamazoo County Adult Drug Treatment Court Outcome and Cost Evaluation: Final Report 2006, NPC Research, Portland, OR.
5. Carpenter C., Dobkin C. Drinking age, alcohol consumption, and crime (working paper) AccessedAugust 31, 2010 at:. http://people.ucsc.edu/~cdobkin/.
6. Garbutt J.C., Kranzler H.R., O'Malley S.S., Gastfriend D.R., Pettinati H.M., Silverman B.L., et al. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: A randomized controlled trial. Journal of the American Medical Association 2005, 293:1617-1625.
7. Glantz M.D., Anthony J.C., Berglund P.A., Degenhardt L., Dierker L., Kalaydjian A., et al. Mental disorders as risk factors for later substance dependence: Estimates of optimal prevention and treatment benefits. Psychological Medicine 2009, 39:1365-1377.
8. Gottfredson D., Najaka S., Kearley B. Effectiveness of drug treatment courts: Evidence from a randomized trial. Criminology and Public Policy 2003, 2:171-196.
9. Greenfield L.A., Henneberg M. Victim and offender self-reports of alcohol involvement in crime. Alcohol Research and Health 2001, 25:20-31.
10. Greenfield A. U.S Department of Justice, Office of Justice Programs; Bureau of Justice Statistics. An analysis of national data on the prevalence of alcohol involvement in crime, Washington D.C. Accessed July 19, 2010 at:. http://bjs.ojp.usdoj.gov/index.cfm?ty=pbdetail&iid=385.
11. Harris A.H., Kivlahan D.R., Bowe T., Humphreys K.N. Pharmacotherapy of alcohol use disorders in the Veterans Health Administration. Psychiatric Services 2010, 61:392-398.
12. Kessler R.C., Wang P.S. The descriptive epidemiology of commonly occurring mental disorders in the United States. Annual Review of Public Health 2008, 29:115-129.
13. Lapham S., Forman R., Alexander M., Illeperuma A., Bohn M.J. The effects of extended-release naltrexone on holiday drinking in alcohol-dependent patients. Journal of Substance Abuse Treatment 2009, 36:1-6.
14. Lapham S.C., McMillan G.P. Open-label pilot study of extended-release naltrexone to reduce drinking and driving among repeat offenders. Journal of Addiction Medicine 2010, Epub ahead of print, doi:10.1097/ADM.0b013e3181eb3b89.
15. Marchand G., Waller M.S., Carey S.M. Barry County adult drug court outcome and cost evaluation: Final report 2006, NPC Research, Portland, OR.
16. Mark T.L., Kassed C.A., Vandivort-Warren R., Levit K.R., Kranzler H.R. Alcohol and opioid dependence medications: Prescription trends, overall and by physician specialty. Drug and Alcohol Dependence 2009, 99:345-349.
17. Mark T.L., Kranzler H.R., Poole V.H., Hagen C.A., McLeod C., Crosse S. Barriers to the use of medications to treat alcoholism. American Journal of Addiction 2003, 12:281-294.
18. Mee-Lee D., Shulman G.D., Fishman M., Gastfriend D.R., Griffith J.H. ASAM patient placement criteria for the treatment of substance-related disorders 2001, American Society of Addiction Medicine, Inc., Chevy Chase, MD. 2nd ed.-Revised (ASAM PPC-2R).
19. National Highway Traffic Safety Administration Traffic safety facts 2008 2009, National Highway Traffic Safety Administration, Washington, DC.
20. Nochajski T.H., Stasiewicz P.R. Relapse to driving under the influence (DUI): A review. Clin Psych Rev 2006, 26:179-195.
21. Nolan J.L. Reinventing justice: The American drug court movement 2001, Princeton University Press, Princeton, NJ.
22. O'Malley S., Garbutt J.C., Gastfriend D.R., Dong Q., Kranzler H.R. Efficacy of extended-release naltrexone (XR-NTX) in alcohol-dependent patients who are abstinent before treatment. Journal of Clinical Psychopharmacology 2007, 27:507-512.
23. Roman J., Townsend W., Bhati A.S. Recidivism rates for drug court graduates: Nationally based estimates (NCJ 201229) 2003, National Institute of Justice, Washington, DC.
24. Rosenbloom D.L. Holidays, triggers, and willpower-Is there a role for medications? A commentary on "The effects of extended-release naltrexone on holiday drinking in alcohol-dependent patients". Journal of Substance Abuse Treatment 2009, 36:7.